Skip to main content
Log in

Effect of Transcatheter Arterial Chemoembolization Combined with Argon–Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is one of the most aggressive tumors in humans. T lymphocytes and natural killer (NK) cells are the body’s first line of defense to prevent tumor cell growth. Previous studies have demonstrated that transcatheter arterial chemoembolization (TACE) combined with argon–helium cryosurgery system (AHCS) can effectively treat liver cancer. However, the mechanism of the treatment is unclear yet. In the current study, we investigated the effects of TACE combined with AHCS on the changes of T cell subsets and NK cells in peripheral blood of HCC. Our data show that alpha-fetoprotein (AFP) levels in peripheral blood were significantly up-regulated in HCC patients before treatment when compared with healthy people and reduced after TACE combined with AHCS treatment (P < 0.01). In addition, we found that CD4+ cells and NK cells decreased (P < 0.05) and CD8+ cells increased (P < 0.05) in HCC patients when compared with healthy people. After treatment, the CD4+ cells, CD4+/CD8+ ratio, and NK cells were dramatically increased in HCC patients (P < 0.05). In contrast, CD8+ cells were significantly decreased (P < 0.05). TACE combined with AHCS treatment significantly prolonged 1-year survival rate of HCC patients and did not show significant side effects. Taken together, our data indicate that TACE combined with AHCS treatment improves patients’ immune system. It is a feasible and effective therapeutic method for HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kubo, S., et al. (1999). Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: A special reference to multicentric carcinogenesis after operation. Hepato-Gastroenterology, 46(30), 3212–3215.

    CAS  PubMed  Google Scholar 

  2. Hao, K., et al. (2009). Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer, 9, 389.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Motoyama, H., et al. (2014). Liver failure after hepatocellular carcinoma surgery. Langenbecks Archives of Surgery, 399(8), 1047–1055.

    Article  Google Scholar 

  4. Chao, Y., et al. (2003). Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Annals of Surgical Oncology, 10(4), 355–362.

    Article  PubMed  Google Scholar 

  5. Chung, S. M., et al. (2014). Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava. Cardiovascular and Interventional Radiology, 37(6), 1507–1515.

    Article  PubMed  Google Scholar 

  6. Grover, I., Ahmad, N., & Googe, A. B. (2014). Hepatogastric fistula following transcatheter arterial chemoembolization of hepatocellular carcinoma. Case Reports in Gastroenterology, 8(3), 286–290.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Gasparini, D., et al. (2002). Combined treatment, TACE and RF ablation, in HCC: Preliminary results. La Radiologia Medica, 104(5–6), 412–420.

    PubMed  Google Scholar 

  8. Chung, J. W., et al. (2006). Transcatheter arterial chemoembolization of hepatocellular carcinoma: Prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean Journal of Radiology, 7(4), 257–266.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Zhang, Y., et al. (2010). The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology, 65(2), 347–352.

    Article  CAS  PubMed  Google Scholar 

  10. Yang, Y., et al. (2012). Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 19(6), 674–684.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Ganz, H., Fülling, J., & Klein, H. (1975). Histological examinations on the hemostatic effect of freezing during surgical procedures in the head and neck (author’s transl). Laryngologie, Rhinologie, Otologie (Stuttg), 54(4), 328–335.

    CAS  Google Scholar 

  12. Li, Y., Wang, F., & Wang, H. (2010). Cell death along single microfluidic channel after freeze-thaw treatments. Biomicrofluidics, 4(1), 14111.

    Article  PubMed  Google Scholar 

  13. Mu, F., et al. (2013). Prevention of needle-tract seeding by two-step freezing after lung cancer biopsy. Pathology & Oncology Research, 19(3), 447–450.

    Article  CAS  Google Scholar 

  14. Dello, S. A., et al. (2014). Influence of preoperative chemotherapy on CT volumetric liver regeneration following right hemihepatectomy. World Journal of Surgery, 38(2), 497–504.

    Article  PubMed  Google Scholar 

  15. Mine, B., Delpierre, I., Hassid, S., & De Witte, O. (2011). The role of interventional neuroradiology in the management of skull base tumours and related surgical complications. B-ENT, 17, 61–66.

    Google Scholar 

  16. Xie, Z. B., et al. (2014). Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review. Tumour Biology, 35(9), 8451–8459.

    Article  CAS  PubMed  Google Scholar 

  17. Polascik, T. J., et al. (2007). Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology, 70(1), 117–121.

    Article  PubMed  Google Scholar 

  18. Gage, A. A., & JG, B. (2004). Cryosurgery for tumors—A clinical overview. Technology in Cancer Research & Treatment, 3(2), 187–199.

    Article  Google Scholar 

  19. Morgan, M. A., et al. (2013). Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery. The Canadian Journal of Urology, 20(5), 6933–6937.

    PubMed  Google Scholar 

  20. Demichev, N. P. (1985). Notes on the hemostatic effect of the cryodestruction of bone tumors. Vestnik khirurgii imeni II Grekova, 135(9), 47–51.

    CAS  Google Scholar 

  21. Liu, J. G., et al. (2011). Cryosurgery for treatment of subcutaneously xenotransplanted tumors in rats and its effect on cellular immunity. Technology in Cancer Research & Treatment, 10(4), 339–346.

    CAS  Google Scholar 

  22. Sidana, A. (2014). Cancer immunotherapy using tumor cryoablation. Immunotherapy, 6(1), 85–93.

    Article  CAS  PubMed  Google Scholar 

  23. Olweny, E. O., & JA, C. (2012). Novel methods for renal tissue ablation. Current Opinion in Urology, 22(5), 379–384.

    Article  PubMed  Google Scholar 

  24. Hashimoto, K., et al. (2012). A surgical case of solitary lymph node metastasis of hepatocellular carcinoma after nonsurgical treatment. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 39(12), 1985–1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoyi Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, M., Wang, X. & Bin, H. Effect of Transcatheter Arterial Chemoembolization Combined with Argon–Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients. Cell Biochem Biophys 73, 787–792 (2015). https://doi.org/10.1007/s12013-015-0699-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0699-0

Keywords

Navigation